Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenmai injection for coronary artery disease with chronic heart failure
ChiCTR-TRC-12003063Phase 4Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of shenmai injection in chronic heart failure (CHF) and coronary arteriosclerosis (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: 6-minute walking test, NYHA cardiac functional classification and 1 more. Started Sep 2011; status: completed.
02
Drugs
shenmai injection
03
Conditions
chronic heart failure (CHF)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12003063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003063.